You can buy or sell TLSA and other stocks, options, ETFs, and crypto commission-free!
Tiziana Life Sciences plc American Depository Share, also called Tiziana Life Sciences, is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. Read More The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.
London, Greater London
52 Week High
52 Week Low
Expected Nov 16, Pre-Market